▽
|
IIPR |
Innovative Industrial Propertie |
Real Estate |
49.0 |
7.5 |
61.0 |
6 |
123.5 |
21.7 |
1.8 |
5.8 |
8.5 |
-26.52 |
53.5 |
1.24 |
|
81.68 |
3, 6, 9, 12 |
2024-11-02 |
Innovative Industrial Properties, Inc. is a self-advised Maryland corporation focused on the acquisition, ownership and management of specialized properties leased to experienced, state-licensed operators for their regulated cannabis facilities. The company has elected to be |
▽
|
ILMN |
Illumina, Inc. |
Healthcare |
28.4 |
|
|
None |
|
-20.5 |
4.2 |
-7.3 |
-20.2 |
-9.31 |
-25.8 |
1.66 |
1.29 |
56.82 |
|
2024-11-02 |
Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis. It operates through Core Illumina and GRAIL segments. The company offers whole-genome sequencing, genotyping, nonin |
▽
|
IMAX |
Imax Corporation |
Communication Services |
20.9 |
|
|
None |
|
50.0 |
4.6 |
0.5 |
9.3 |
-27.09 |
6.8 |
1.97 |
1.83 |
33.53 |
|
2024-11-02 |
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the |
▽
|
IMKTA |
Ingles Markets, Incorporated |
Consumer Defensive |
14.3 |
0.8 |
9.0 |
0 |
4.6 |
4.5 |
0.6 |
14.5 |
14.4 |
-7.79 |
3.6 |
2.88 |
1.39 |
58.98 |
1, 3, 4, 5, 6, 7, 9, 10, 12 |
2024-11-02 |
Ingles Markets, Incorporated, together with its subsidiaries, operates a chain of supermarkets in the southeast United States. It offers food products, including grocery, meat and dairy products, produce, frozen foods, and other perishables. The |
▽
|
IMMR |
Immersion Corporation |
Technology |
13.1 |
3.2 |
|
0 |
20.8 |
7.9 |
1.5 |
1.1 |
18.6 |
-2.86 |
100.2 |
8.93 |
|
84.88 |
1, 4, 7, 10 |
2024-11-02 |
Immersion Corporation, together with its subsidiaries, engages in the creation, design, development, and licensing of haptic technologies. The company provides technology, patent, and combined licenses. It serves markets, including mobility, gaming, automotive, |
▽
|
IMNM |
Immunome, Inc. |
Healthcare |
59.0 |
|
|
None |
|
-6.8 |
6.0 |
-1.7 |
-89.1 |
-100.00 |
|
6.63 |
|
80.71 |
|
2024-11-02 |
Immunome, Inc. develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor. |
▽
|
IMVT |
Immunovant, Inc. |
Healthcare |
85.5 |
|
|
None |
|
-16.6 |
7.0 |
-1.8 |
-42.0 |
|
|
13.70 |
|
92.71 |
|
2024-11-02 |
Immunovant, Inc. is a clinical-stage biopharmaceutical company. The company develops monoclonal antibodies for the treatment of autoimmune diseases. Its lead product is batoclimab, a novel fully human mon |
▽
|
IMXI |
International Money Express, In |
Technology |
15.2 |
|
|
None |
|
9.6 |
3.8 |
1.8 |
39.9 |
-18.41 |
9.0 |
1.94 |
|
25.84 |
|
2024-11-02 |
International Money Express, Inc. operates as an omnichannel money remittance services company in the United States, Latin America, Mexico, Central and South America, the Caribbean, Africa, and Asia. It provides services through sending and paying |
▽
|
INBX |
Inhibrx Biosciences, Inc. |
Healthcare |
|
|
|
None |
|
-1.5 |
-28.7 |
-10.7 |
1943.6 |
-20.38 |
-9483.7 |
0.41 |
|
-30.67 |
|
2024-11-02 |
Inhibrx Biosciences, Inc. engages in the development of biologic therapeutics for people with life-threatening conditions. Its therapeutic candidates includes INBRX-109, a tetravalent therapeutic candidate targeting death |
▽
|
INCY |
Incyte Corporation |
Healthcare |
24.5 |
|
|
None |
|
24.5 |
2.8 |
3.1 |
11.5 |
-10.29 |
16.2 |
3.75 |
3.69 |
76.52 |
|
2024-11-02 |
Incyte Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics for hematology/oncology, and inflammation and autoimmunity areas. It offers JAK |